Stelara 130 MG/26 ML vial 26ML
Ended Awarded
- Contract number
- SPE2DB25FH4YZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,050
Award facts
- Contract value 100% obligated
- $5,049.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Stelara 130 mg/26 ml vials. The contract, valued at $5,049.84 with a firm fixed price structure, represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, demonstrating the company's competitive position in federal pharmaceutical procurement as a woman-owned small business. Performance is scheduled for completion by May 12, 2025, with fulfillment at the company's Park Ridge, Illinois location.
This delivery order supports the DLA's mission to supply pharmaceutical products to Department of Defense healthcare facilities nationwide. Stelara is a biologic medication used to treat various inflammatory conditions and is part of the comprehensive pharmaceutical portfolio that DMS Pharmaceutical Group provides to military health facilities. The company's established role as a critical supplier within the federal pharmaceutical supply chain, combined with its SPE2DB program IDC with DLA, enables the agency to efficiently procure specialized pharmaceutical items to support military medical operations and personnel healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FH4YZ?
SPE2DB25FH4YZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 21, 2025.
How much is contract SPE2DB25FH4YZ worth?
The government has obligated $5,050 on SPE2DB25FH4YZ.
Is contract SPE2DB25FH4YZ an order under another contract?
Yes. SPE2DB25FH4YZ is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH4YZ competed?
The extent of competition for SPE2DB25FH4YZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award